TrialGut2001

Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses.

W Kruis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.